Akamai Technologies Total Cost of Revenue increased by 4.2% to $471.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $418.95M to $471.30M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 8.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $320.00M | $316.87M | $325.40M | $332.75M | $346.65M | $346.45M | $357.97M | $361.32M | $373.28M | $383.08M | $393.40M | $394.74M | $402.89M | $408.81M | $414.36M | $418.95M | $426.54M | $429.53M | $452.50M | $471.30M |
| QoQ Change | — | -1.0% | +2.7% | +2.3% | +4.2% | -0.1% | +3.3% | +0.9% | +3.3% | +2.6% | +2.7% | +0.3% | +2.1% | +1.5% | +1.4% | +1.1% | +1.8% | +0.7% | +5.3% | +4.2% |
| YoY Change | — | — | — | — | +8.3% | +9.3% | +10.0% | +8.6% | +7.7% | +10.6% | +9.9% | +9.3% | +7.9% | +6.7% | +5.3% | +6.1% | +5.9% | +5.1% | +9.2% | +12.5% |